Ackerman, M. J., McKenna, W. J., Thierfelder, L. et al. Mutations in the genes for cardiac troponins T and alpha tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med., 332:1058–64, 1995.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol., 42:1688–1713, 2003.
Boriani, G., Maron, B. J., Win-Kuang, S. et al. Prevention of sudden death in hypertrophic cardiomyopathy: But which defibrillator for which patient? Circulation, 110:e438–e442, 2004.
Braunwald, E., Seidman, C. E., and Sigwart, U. Contemporary evalua¬tion and management of hypertrophic cardiomyopathy. Circulation, 106:1312–1316, 2002.
Brock, R. Functional obstruction of the left ventricle. Guy’s Hospital Rev., 106:221, 1957.
Canon, R. O. Assessing risk in hypertrophic cardiomyopathy. N. Engl. J. Med., 349:1016–18, 2003.
Cice, G., Ferrara, L., Benedetto, A. D. et al. Dilated cardiomyopathy in dialysis patients. Beneficial effects of carvedilol, a double-blind, placebo-controlled trial. J. Am. Coll. Cardiol., 57:47–11, 2001.
Elliott, P. M., Blanes, G., Mahon, J. R. et al. A relation between the
severity of left ventricular hypertrophy and prognosis in patients with

Страницы: 1 | 2 | 3 | 4